methylprednisolone has been researched along with Vaginal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, S; Ihn, H; Itai, H; Kimura, T; Kubo, Y; Kuriyama, H; Miyamoto, H; Miyashita, A; Nakahara, S; Tsukamoto, H | 1 |
| Carreño, CA; Gadea, M | 1 |
2 other study(ies) available for methylprednisolone and Vaginal Neoplasms
| Article | Year |
|---|---|
Nivolumab-induced colitis in a patient with malignant melanoma: A case report and immunological analysis.
Topics: Antineoplastic Agents, Immunological; Biopsy; Colitis; Colon; Colonoscopy; Dose-Response Relationship, Drug; Female; Humans; Intestinal Mucosa; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Methylprednisolone; Middle Aged; Nivolumab; Tomography, X-Ray Computed; Vaginal Neoplasms | 2019 |
Case report of a kidney transplant recipient converted to everolimus due to malignancy: resolution of bronchiolitis obliterans organizing pneumonia without everolimus discontinuation.
Topics: Adrenal Cortex Hormones; Azathioprine; Cryptogenic Organizing Pneumonia; Cyclosporine; Everolimus; Female; Humans; Kidney Transplantation; Methylprednisolone; Middle Aged; Papillomavirus Infections; Polycystic Kidney Diseases; Postoperative Complications; Sirolimus; Vaginal Neoplasms | 2007 |